Tonix Pharma (TNXP) Tops Q1 EPS by 16c

Tonix Pharma (NASDAQ: TNXP) reported Q1 EPS of ($0.18), $0.16 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $2.48 million versus the consensus estimate of $3.87 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)